The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells
Open accessAbstract
Culture of human peripheral blood lymphocytes (PBL) in partially purified and lectin-free interleukin 2 results in the generation of cytotoxic effector cells which have the unique property of lysing natural killer (NK)-resistant fresh human tumor cells. We have termed these effector cells "lymphokine- activated killer" cells (LAK). LAK are generated from both normal and cancer patients' PBL and are able to lyse both autologous and allogeneic tumor cells from all histologic tumor types tested. Our previous studies suggested that the LAK phenomenon was distinct from either the cytotoxic thymus-derived lymphocyte (CTL) or NK systems based on a variety of criteria. This study reports that the cell type involved is also distinct, as determined by phenotypic characteristics. The LAK effector cell phenotype was analyzed in parallel with alloimmune CTL, and LAK were found to be similarly susceptible to the monoclonal anti-T cell antibodies OKT-3 or OKT-8 plus complement. In contrast the LAK precursor was not susceptible to the OKT-3 or Leu-1 antibodies plus complement, while the ability to generate alloimmune CTL was totally obliterated when tested using the same PBL responder population; in fact, generation of LAK was found to be augmented five- to sixfold, clearly suggesting that LAK precursor cells are not T lymphocytes as defined by these antibodies. LAK precursors were found to be abundant in NK cell-enriched Percoll gradient fractions, which had been depleted of the 29 degrees C E- rosetting "high affinity" T cells. However, LAK precursors were found to be distinct from the majority of NK cells since lysis of fresh PBL with the monoclonal antibodies OKM-1, Leu-7, or OKT-11 significantly depleted or totally eliminated NK activity, while subsequent activation of the remaining cells generated high levels of LAK and in some cases augmented levels of LAK. LAK precursors were found to be distributed in the thymus, bone marrow, spleen, lymph node, and thoracic duct in addition to the PBL. Therefore, while the cell(s) responsible for activation and expression of LAK activity have some common features with the classic T cell-mediated CTL and NK cell systems, the LAK precursor cells are clearly distinct as determined by phenotype analysis using monoclonal antibodies and complement, and at present must be classified as a "null" cell.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grimm, E. A., Mazumder, A., Zhang, H. Z., & Rosenberg, S. A. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.6.1823 · Cited by 2,204
Self-citationMonoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens
Kung, P. C., Goldstein, G., Reinherz, E. L., & Schlossman, S. F. (1979) · Science · doi:10.1126/science.314668 · Cited by 1,453
A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).
Abo, T., & Balch, C. M. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.3.1024 · Cited by 1,398
Reinherz, E. L., Kung, P. C., Goldstein, G., & Schlossman, S. F. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.3.1301 · Cited by 691
Natural Killer Cells: Characteristics and Regulation of Activity
Herberman, R. B., Djeu, J. Y., Kay, H. D., Ortaldo, J. R., Riccardi, C., Bonnard, G. D., Holden, H. T., Fagnani, R., Santoni, A., & Puccetti, P. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00267.x · Cited by 575
Self-citationLysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
Lotze, M. T., Grimm, E. A., Mazumder, A., Strausser, J. L., & Rosenberg, S. A. (1981) · PubMed · Cited by 523
Self-citationIsolation of human NK cells by density gradient centrifugation
Timonen, T. T., & SAKSELA, E. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90133-7 · Cited by 456
Ortaldo, J. R., Sharrow, S. O., Timonen, T., & Herberman, R. B. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2401 · Cited by 389
Engleman, E. G., Benike, C. J., Grumet, F. C., & Evans, R. L. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.5.2124 · Cited by 337
Verbi, W., Greaves, M. F., Schneider, C., Koubek, K., Janossy, G., Stein, H., Kung, P., & Goldstein, G. (1982) · European Journal of Immunology · doi:10.1002/eji.1830120115 · Cited by 288
Yron, I., Wood, T. A., Spiess, P. J., & Rosenberg, S. A. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.1.238 · Cited by 264
Self-citationHuman homologue of murine T200 glycoprotein.
Omary, M. B., Trowbridge, I. S., & Battifora, H. A. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.4.842 · Cited by 189
Phenotypes of human natural killer cell populations detected with monoclonal antibodies.
Zarling, J. M., Clouse, K. A., Biddison, W. E., et al. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2575 · Cited by 166
Timonen, T. T., Ortaldo, J. R., & Herberman, R. B. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.6.2514 · Cited by 141
Seeley, J. K., Masucci, G. V., Poros, A., et al. (1979) · PubMed · Cited by 124
Masucci, M. G., Klein, E., & Argov, S. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.5.2458 · Cited by 109
Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.
Mazumder, A., Grimm, E. A., Zhang, H. Z., & Rosenberg, S. A. (1982) · PubMed · Cited by 99
Self-citationStudies of human natural killer cells. II. Analysis at the single cell level.
Rubin, P., Pross, H. F., & Roder, J. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.6.2553 · Cited by 53
Bolhuis, R. L. H., & Schellekens, H. (1981) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1981.tb00151.x · Cited by 45
Cited by
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132327 · Cited by 2,653
Self-citationRosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812223192527 · Cited by 2,389
Self-citationIL-2: The First Effective Immunotherapy for Human Cancer
Rosenberg, S. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1490019 · Cited by 1,289
Self-citationBiology and clinical relevance of human natural killer cells
Robertson, M., & Ritz, J. (1990) · Blood · doi:10.1182/blood.v76.12.2421.2421 · Cited by 931
Metadata
- Authors
- Grimm, E., Ramsey, K., Mazumder, A., Wilson, D., Djeu, J., & Rosenberg, S.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1983-03-01
- Volume
- 157
- Issue
- 3
- Pages
- 884-897
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2081219792
- Cited by
- 467
- References
- 19
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.